What was the number of stock options outstanding for Baymont Inn Suites as of December 31, 2023?
Baymont_Inn_Suites Franchise · 2025 FDDAnswer from 2025 FDD Document
| Number of Options | Weighted Average Exercise Price | Weighted Average Remaining Contractual Life (Years) | Aggregate Intrinsic Value (in millions) | ||
|---|---|---|---|---|---|
| Outstanding as of December 31, 2023 | 1.0 | $ | 55.89 | ||
| Granted | — | — | |||
| Exercised | (0.4) | 58.43 | |||
| Canceled | — | — | |||
| Outstanding as of December 31, 2024 | 0.6 | $ | 54.45 | 2.5 | $ 31 |
| Unvested as of December 31, 2024 | — | $ | — | 0 | $ — |
| Exercisable as of December 31, 2024 | 0.6 | $ | 54.11 | 2.5 | $ 31 |
There were no stock options granted in 2024 or 2023. The activity related to stock options for the year ended December 31, 2024 consisted of the following:
Source: Item 23 — RECEIPTS (FDD pages 97–443)
What This Means (2025 FDD)
According to Baymont Inn Suites's 2025 Franchise Disclosure Document, as of December 31, 2023, the number of stock options outstanding was 1.0. The weighted average exercise price was $55.89.
By December 31, 2024, the number of outstanding options decreased to 0.6, with a weighted average exercise price of $54.45 and a weighted average remaining contractual life of 2.5 years. The aggregate intrinsic value was $31 million. During 2024, 0.4 options were exercised with a weighted average exercise price of $58.43.
There were no stock options granted in 2024 or 2023. These figures reflect the stock option activity related to Baymont Inn Suites.